Dying on Dialysis: The Case for a Dignified Withdrawal - PMC - NCBI
www.ncbi.nlm.nih.gov › PMC3878704
Aug 22, 2013 · Acceleration of comorbid illness in patients undergoing long-term maintenance hemodialysis may be manifested by clinical deterioration that ...
Fifteen-year trajectories of multimorbidity and polypharmacy in ...
www.ncbi.nlm.nih.gov › PMC8880753
After stratifying for age, sex and multimorbidity at baseline, our aim is to analyse time trends in incident multimorbidity and polypharmacy in the 15-year ...
Missing: PMC3878704/ | Show results with:PMC3878704/
People also ask
How long can an 80 year old live with kidney failure without dialysis?
What is the longest someone has lived after stopping dialysis?
What are the chances of getting off dialysis?
What is the main reason for kidney failure?
To utilise a patient centred care approach through shared decision-making when caring for patients and families who are considering dialysis withdrawal. To ...
Jan 24, 2022 · Dear Editor,. The mechanistic pathways leading to immune dysregulation and complications driven by uncontrolled severe acute respiratory ...
Missing: PMC3878704/ | Show results with:PMC3878704/
This paper presents a rationale for and an objective approach to initiating and managing dialysis withdrawal for patients who wish to withdraw because of ...
Missing: pmc/ articles/
Mar 16, 2020 · The aims of our study were to evaluate the impact of diabetes mellitus and obesity on skin and subcutaneous tissues. In particular, we can ...
Missing: PMC3878704/ | Show results with:PMC3878704/
This study has evaluated differentiation of tyrosine hydroxylase-immunopositive neurons in the suprachiasmatic nucleus as well as the innervation of this ...
Missing: pmc/ articles/ PMC3878704/
Modified Selective Dorsal Rhizotomy Exposure Method for Adults With ...
pubmed.ncbi.nlm.nih.gov › ...
Dec 12, 2023 · In this article, we introduce a more minimally invasive SDR procedure in adult patients with spastic paralysis of the lower limbs. Methods ...
Missing: pmc/ PMC3878704/
Ramucirumab, a most recent antiangiogenic drug, is vying in the race to metastatic CRC (mCRC) treatment since its approval by the Food and Drug Administration ( ...
Missing: pmc/ PMC3878704/
Mar 1, 2024 · Abstract. [This corrects the article DOI: 10.3389/fonc.2023.1223282.]. Keywords: bone metastases; lenvatinib; liver metastases; ...
Missing: pmc/ PMC3878704/
In order to show you the most relevant results, we have omitted some entries very similar to the 10 already displayed.
If you like, you can repeat the search with the omitted results included. |